Literature DB >> 20359657

Molecular subtyping of breast cancer: ready to use?

Jorma de Ronde, Lodewyk Wessels, Jelle Wesseling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20359657     DOI： 10.1016/S1470-2045(10)70036-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection.

Authors:  Shyam A Patel; Meneka A Dave; Raghav G Murthy; Karim Y Helmy; Pranela Rameshwar
Journal:  Oncol Rev       Date:  2011-06-01

2.  Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.

Authors:  E K A Millar; P H Graham; C M McNeil; L Browne; S A O'Toole; A Boulghourjian; J H Kearsley; G Papadatos; G Delaney; C Fox; E Nasser; A Capp; R L Sutherland
Journal:  Br J Cancer       Date:  2011-06-28       Impact factor: 7.640

3.  Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.

Authors:  André Hennigs; Fabian Riedel; Adam Gondos; Peter Sinn; Peter Schirmacher; Frederik Marmé; Dirk Jäger; Hans-Ulrich Kauczor; Anne Stieber; Katja Lindel; Jürgen Debus; Michael Golatta; Florian Schütz; Christof Sohn; Jörg Heil; Andreas Schneeweiss
Journal:  BMC Cancer       Date:  2016-09-15       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.